Loading...

PODCAST

BiotechTV - News

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

science life sciences

All Episodes

00:19:34

NewLimit raised a $130M series B round last week to...

BiotechTV - News ·

2025/05/12

Co-Founder & President Jacob Kimmel and Head of Operations Cathy O'Hare describe the scientific approach and how it benefits from the crossroads of genomics and machine learning. Plus, which indications the company plans to start out in clinically.

en-us

00:19:03

Biotech investor Christoph Broja of EQT Life Sciences...

BiotechTV - News ·

2025/05/09

He describes the current environment for life sciences in Europe and how far it has come over the last ten years. Plus, his thoughts on the value of being local for uncovering opportunities, and the state of the capital markets.

en-us

00:13:18

With a phase 3 trial for its PRAME cell therapy...

BiotechTV - News ·

2025/05/09

CEO Harpreet Singh joins us from the company's office in Munich, Germany, where he describes the founding of the company and previews catalysts to watch for over the year ahead.

en-us

00:06:59

Mosaic Therapeutics, which uses advanced...

BiotechTV - News ·

2025/05/09

Interim CEO Magda Jonikas describes Mosaic's platform and the rationale behind these two targets the company has licensed in.

en-us

00:09:44

Cambridge, UK based Epitopia is helping Merck (MSD)...

BiotechTV - News ·

2025/05/09

CEO Alan Rigby talks about the work Epitopia does finding "Crypotgen" antigens for its own off-the-shelf cancer vaccines, and discusses what was appealing to Merck about the partnership.

en-us

00:16:49

Munich based Tubulis is working on ADCs that it...

BiotechTV - News ·

2025/05/08

Co-Founder and CEO Dominik Schumacher describes what he thinks can be improved on from the current generation of antibody-drug conjugates, and the science behind how Tubilis is designing its ADCs differently. He highlights the company's clinical Napi2b and 5T4 programs.

en-us

00:19:33

As the field builds on the initial success of PARP...

BiotechTV - News ·

2025/05/08

CEO Niall Martin walks us through the current state of this corner of drug development, and then highlights data presented at AACR last week for its ATR kinase inhibitor. As he describes, patient selection for these therapies can make a big difference.

en-us

00:20:34

Munich based ITM Radiopharma is progressing towards a...

BiotechTV - News ·

2025/05/08

CEO Andrew Cavey describes how ITM has been investing to avoid the shortages others have experienced, and explains how the supply chain works for radiopharmaceuticals. He walks us through the science behind these medicines before highlighting ITM's pipeline.

en-us

00:15:43

Munich based Ethris is developing a proprietary mRNA...

BiotechTV - News ·

2025/05/07

CEO Carsten Rudolph and CMO Thomas Langenickel describe the technology, which can be spray dried and shipped in a dry powder formulation, and also the clinical experience so far on the lead program in asthma.

en-us

00:07:45

Swiss Biotech Day: Geneva based Light Chain...

BiotechTV - News ·

2025/05/06

CEO Nicolas Fischer describes the rationale of designing bi-specifics this way, and walks us through the company's programs, which mostly have a CD47 or CD28 backbone.

en-us

00:08:56

Swiss Biotech Day: Milan based Genenta Science...

BiotechTV - News ·

2025/05/06

Co-Founder and CEO Pierluigi Paracchi describes the terms of the convertible bond raise, which gives the investor, ENEA Tech and Biomedical, the opporutnity to convert to equity in three years. He also provides an update on the progress of dosing renal cell carcinoma patients in the clinic, and what we can expect from the trial throughout the rest of the year.

en-us

00:09:38

Swiss Biotech Day: Lausanne based Tigen Pharma is...

BiotechTV - News ·

2025/05/06

Chairman & CEO Emmanuel Savioz describes the benefits of decentralized manufacturing that is at or near the site of treatment. He highlights an armored-CAR AML program the company has with MSK in New York, and discusses Tigen's non-viral platform for NHL and multiple myeloma.

en-us

00:10:29

Swiss Biotech Day: Lausanne based Vandria is focused...

BiotechTV - News ·

2025/05/06

CEO Klaus Dugi describes why the company is focused on mitochondria and how it using small molecules to fix them. He covers the three main disease areas Vandria is focused on, including a clinical program in mild cognitive impairment.

en-us

00:10:32

Swiss Biotech Day: Basel based BioVersys successfully...

BiotechTV - News ·

2025/05/06

Co-Founder & CEO Marc Gitzinger describes the success factors behind the IPO and walks us through the company's two lead programs. Plus, his thoughts on the evolving business model for this field.

en-us

00:07:35

Swiss Biotech Day: Zurich based LimmaTech Biologics...

BiotechTV - News ·

2025/05/05

CEO Franz-Werner Haas describes the rationale for developing vaccines for the antimicrobial space, he explains the company's E. coli based platform, and he walks us through the pipeline.

en-us

00:08:59

Swiss Biotech Day: Basel based Nouscom presented data...

BiotechTV - News ·

2025/05/05

CEO Marina Udier describes the vaccine's design, what was presented at AACR, and discussions the company has had with U.S. FDA about running a registrational study. Plus, previewing upcoming data later this year in metastatic colorectal cancer.

en-us

00:13:21

Swiss Biotech Day: Molecular Partners' CEO and Swiss...

BiotechTV - News ·

2025/05/05

He describes the clinical multi-specific T-cell engager program that will have data this year, and highlights the idea behind a next-generation logic-gating platform. Plus, entering the clinic with a DLL3 radio-DARPin and choosing mesothelin as a second target.

en-us

00:07:55

At a reception on the eve of Swiss Biotech Day, Swiss...

BiotechTV - News ·

2025/05/04

He describes the goals of Swiss Biotech Day, explains how the Swiss biotech sector is funded more by private investment than perhaps other geographies, and discusses current events.

en-us

00:23:52

Biotech investor Thilo Schroeder of Nextech Invest...

BiotechTV - News ·

2025/05/02

He describes the history of Nextech, including being an early investor in Blueprint Medicines and Peloton, and discusses the importance of investing in companies that have a wide moat to protect from today's fierce global competition.

en-us

00:12:28

VERAXA Biotech, which is part of Switzerland's Xlife...

BiotechTV - News ·

2025/05/02

Xlife Sciences CEO Oliver Baumann introduces us to the fund, which is publicly traded in Switzerland, while VERAXA CEO Christoph Antz describes the BiTAC AND-gating platform the company uses to improve on the precision of T-cell engagers and antibody-drug conjugates.

en-us

486 results

Similar Podcasts

Astounding Stories 10

Ray Cummings

Das Wissen | SWR

SWR

Rabbit Hole of Research

Jotham Austin, II PhD, Nick Elizalde,...

תל אביב 360 – ערוץ הפודקסטים של אוניברסיטת תל אביב

Tel Aviv University

2026 Nuestro Oxígeno 10- Octubre

Nuestro Oxígeno